Skip to main navigation Skip to search Skip to main content

Retrospective Analysis of the Safety and Efficacy of Brentuximab Vedotin in Patients Aged 60 Years or Older with Relapsed or Refractory CD30+ Hematologic Malignancies

  • Michelle A. Fanale
  • , Nancy L. Bartlett
  • , Andres Forero-Torres
  • , Anas Younes
  • , Robert W. Chen
  • , Jonathan W. Friedberg
  • , Jeffrey V. Matous
  • , Andrei R. Shustov
  • , Scott E. Smith
  • , Jasmine Zain
  • , Megan M. O'Meara
  • , Ajay K. Gopal
  • University of Texas MD Anderson Cancer Center
  • Washington University in St. Louis
  • University of Alabama at Birmingham
  • City of Hope National Medical Center
  • University of Rochester
  • Colorado Blood Cancer Institute, Denver, CO, USA,
  • University of Washington Medical Center
  • Loyola University Medical Center
  • New York University
  • Seattle Genetics

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume120
Issue number21
DOIs
StatePublished - Nov 16 2012
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Gerontology
  • Internal Medicine

Cite this